Candel Therapeutics (CADL) Interest & Investment Income: 2020-2023
Historic Interest & Investment Income for Candel Therapeutics (CADL) over the last 4 years, with Dec 2023 value amounting to $415,000.
- Candel Therapeutics' Interest & Investment Income fell 48.38% to $415,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year increase of 99.71%. This contributed to the annual value of $1.1 million for FY2024, which is 47.81% down from last year.
- Per Candel Therapeutics' latest filing, its Interest & Investment Income stood at $415,000 for Q4 2023, which was down 17.33% from $502,000 recorded in Q3 2023.
- Candel Therapeutics' 5-year Interest & Investment Income high stood at $804,000 for Q4 2022, and its period low was -$175,000 during Q1 2022.
- Over the past 3 years, Candel Therapeutics' median Interest & Investment Income value was $206,500 (recorded in 2022), while the average stood at $255,917.
- Data for Candel Therapeutics' Interest & Investment Income shows a peak YoY increase of 7,409.09% (in 2022) and a maximum YoY decrease of 1,358.33% (in 2022) over the last 5 years.
- Quarterly analysis of 4 years shows Candel Therapeutics' Interest & Investment Income stood at $49,000 in 2020, then crashed by 122.45% to -$11,000 in 2021, then surged by 7,409.09% to $804,000 in 2022, then tumbled by 48.38% to $415,000 in 2023.
- Its Interest & Investment Income stands at $415,000 for Q4 2023, versus $502,000 for Q3 2023 and $453,000 for Q2 2023.